PSA Vice President Professor Mark Naunton MPS[/caption]
The new normal
A new PSA report describes the digital future of Australian health care, a ‘new normal’ with pharmacists front and centre, equipped with more information...
Calculating the risk of glaucoma
More than 1000 people have completed an online assessment in Australian pharmacies to determine their potential risk of developing glaucoma, and there's a call...
Sun safety: don’t feel the burn
Australia has the highest rates of skin cancer in the world, with at least 2 in 3 Australians diagnosed by the age of 70.
Indirect impacts of COVID-19
Australia has had relative success in suppressing the COVID-19 virus, but there continues to be myriad ongoing and wide ranging indirect impacts.
Clinical governance: shared responsibility, a common goal
New principles will help guide design and delivery of high-quality pharmacy services.
We have a high-quality health system in Australia, and a first-class pharmacy...
Reducing stroke risk in dementia patients
A commonly-used treatment for Alzheimer's disease could reduce the risk of stroke among people with dementia.
The Australian-Swedish study, co-authored by Monash University researchers, focussed...
